NDC 54575-270
KAPOK
Ceiba Pentandra Fiber
KAPOK is a Percutaneous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Allergy Laboratories, Inc.. The primary component is Ceiba Pentandra Fiber.
| Product ID | 54575-270_dbe7bebd-e445-4e59-8302-e706b795fbde |
| NDC | 54575-270 |
| Product Type | Human Prescription Drug |
| Proprietary Name | KAPOK |
| Generic Name | Ceiba Pentandra Fiber |
| Dosage Form | Injection, Solution |
| Route of Administration | PERCUTANEOUS; SUBCUTANEOUS |
| Marketing Start Date | 1967-12-07 |
| Marketing Category | BLA / BLA |
| Application Number | BLA101376 |
| Labeler Name | Allergy Laboratories, Inc. |
| Substance Name | CEIBA PENTANDRA FIBER |
| Active Ingredient Strength | 1 g/20mL |
| Pharm Classes | Non-Standardized Plant Fiber Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Plant Proteins [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
Packaging
NDC 54575-270-30
30 mL in 1 VIAL, MULTI-DOSE (54575-270-30)
| Marketing Start Date | 1967-12-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 54575-270-30 [54575027030]
KAPOK INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA101376 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1967-12-07 |
| Inactivation Date | 2020-01-31 |
NDC 54575-270-10 [54575027010]
KAPOK INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA101376 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1967-12-07 |
| Inactivation Date | 2020-01-31 |
NDC 54575-270-02 [54575027002]
KAPOK INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA101376 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1967-12-07 |
| Inactivation Date | 2020-01-31 |
NDC 54575-270-50 [54575027050]
KAPOK INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA101376 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1967-12-07 |
| Inactivation Date | 2020-01-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| CEIBA PENTANDRA FIBER | 1 g/20mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Plant Fiber Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Plant Proteins [CS]
- Allergens [CS]
NDC Crossover Matching brand name "KAPOK" or generic name "Ceiba Pentandra Fiber"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 22840-1527 | Kapok | Ceiba pentandra |
| 22840-1529 | Kapok | Ceiba pentandra |
| 22840-1558 | Kapok | Ceiba pentandra |
| 22840-5514 | Kapok | Ceiba pentandra |
| 36987-2226 | Kapok | Kapok |
| 36987-2227 | Kapok | Kapok |
| 36987-2228 | Kapok | Kapok |
| 36987-2229 | Kapok | Kapok |
| 49288-0285 | Kapok | Kapok |
| 49643-017 | Kapok | Kapok |
| 54575-270 | KAPOK | ceiba pentandra fiber |
| 0268-0635 | CEIBA PENTANDRA FIBER | KAPOK |
| 0268-6312 | CEIBA PENTANDRA FIBER | Kapok |
Trademark Results [KAPOK]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 KAPOK 88545213 not registered Live/Pending |
Weishen Wang 2019-07-29 |
 KAPOK 88422046 not registered Live/Pending |
Zeng Minhua 2019-05-09 |
 KAPOK 88258298 not registered Live/Pending |
Scott Barrett 2019-01-11 |
 KAPOK 87879639 5617030 Live/Registered |
Tiltech Co., Ltd 2018-04-17 |
 KAPOK 87296362 5455361 Live/Registered |
Chen Fuyu 2017-01-11 |
 KAPOK 86676332 not registered Dead/Abandoned |
Scott Barrett 2015-06-26 |
 KAPOK 79052889 3572879 Live/Registered |
GUANGZHOU KAPOK MUSICAL INSTRUMENT CO., 2008-04-01 |
 KAPOK 77876792 3912174 Live/Registered |
Kapok LLC 2009-11-19 |
 KAPOK 76536137 2883876 Dead/Cancelled |
NG, Franklin T.Y. 2003-07-28 |
 KAPOK 74233499 1730607 Dead/Cancelled |
HEALTH CARE OF AMERICA, INC. 1991-12-26 |
 KAPOK 73548029 1408412 Dead/Cancelled |
CHINA NATIONAL LIGHT INDUSTRIAL PRODUCTS IMPORT & EXPORT CORP. 1985-07-15 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.